Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2018

Open Access 01-12-2018 | Case report

Pheochromocytoma as a rare cause of hypertension in a 46 X, i(X)(q10) turner syndrome: a case report and literature review

Authors: Ji Yeon Shin, Bo Hyun Kim, Young Keum Kim, Tae Hwa Kim, Eun Heui Kim, Min Jin Lee, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim

Published in: BMC Endocrine Disorders | Issue 1/2018

Login to get access

Abstract

Background

Cardiovascular disease (CVD) presents the most serious health problems and contributes to the increased mortality in young women with Turner syndrome. Arterial hypertension in Turner syndrome patients is significantly more prevalent than that in a general age-matched control group. The aetiology of hypertension in Turner syndrome varies, even in the absence of cardiac anomalies and obvious structural renal abnormalities. Pheochromocytoma is an extremely rare cause among various etiologies for hypertension in patients with Turner syndrome. Here, we reported a pheochromocytoma as a rare cause of hypertension in Turner syndrome patient.

Case presentation

A 21-year-old woman who has diagnosed with Turner syndrome with a karyotype of 46,X,i(X)(q10) visited for hypertension and mild headache. Transthoracic echography (TTE) showed no definite persistent ductus arteriosus shunt flow and cardiac valve abnormalities. Considering other important secondary causes like pheochromocytoma, hormonal studies were performed and the results showed increased serum norepinephrine, serum normetanephrine, and 24 h urine norepinephrine. We performed an abdominal computed tomography (CT) to confirm the location of pheochromocytoma. Abdominal CT showed a 1.9 cm right adrenal mass. I-131 meta-iodobenzylguanidine (MIBG) scintigraphy showed a right adrenal uptake. Laparoscopic adrenalectomy was performed and confirmed a pheochromocytoma. After surgery, blood pressure was within normal ranges and postoperative course was uneventful, and no recurrence developed via biochemical tests and abdominal CT until 24 months.

Conclusion

Our case and previous literatures suggest that hypertension caused by pheochromocytoma which is a rare but important and potentially lethal cause of hypertension in Turner syndrome. This case underlines the importance of early detection of pheochromocytoma in Turner syndrome. Clinicians should keep in mind that pheochromocytoma can be a cause of hypertension in patients with Turner syndrome.
Literature
1.
go back to reference Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in turner syndrome. J Clin Endocrinol Metab. 2006;91:3897–902.CrossRefPubMed Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in turner syndrome. J Clin Endocrinol Metab. 2006;91:3897–902.CrossRefPubMed
2.
go back to reference Gravholt CH. Clinical practice in turner syndrome. Nat Clin Pract Endocrinol Metab. 2005;1:41–52.CrossRefPubMed Gravholt CH. Clinical practice in turner syndrome. Nat Clin Pract Endocrinol Metab. 2005;1:41–52.CrossRefPubMed
3.
go back to reference Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in turner syndrome. J Hypertens. 2006;24:353–60.CrossRefPubMed Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in turner syndrome. J Hypertens. 2006;24:353–60.CrossRefPubMed
4.
go back to reference Bondy CA. Turner syndrome study group. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab. 2007;92:10–25.CrossRefPubMed Bondy CA. Turner syndrome study group. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab. 2007;92:10–25.CrossRefPubMed
5.
go back to reference Pedreira CC, Hameed R, Kanumakala S, Zacharin M. Health-care problems of turner syndrome in the adult woman: a cross sectional study of a Victorian cohort and a case for transition. Intern Med J. 2006;36:54–7.CrossRefPubMed Pedreira CC, Hameed R, Kanumakala S, Zacharin M. Health-care problems of turner syndrome in the adult woman: a cross sectional study of a Victorian cohort and a case for transition. Intern Med J. 2006;36:54–7.CrossRefPubMed
6.
go back to reference De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, Tʼsjoen G, De Backer T. Arterial hypertension in turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J Hypertens. 2015;33:1342–51.PubMed De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, Tʼsjoen G, De Backer T. Arterial hypertension in turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J Hypertens. 2015;33:1342–51.PubMed
7.
go back to reference Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylvén L, Baandrup U, Kristensen BØ, Christiansen JS. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young. 2006;16:430–6.CrossRefPubMed Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylvén L, Baandrup U, Kristensen BØ, Christiansen JS. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young. 2006;16:430–6.CrossRefPubMed
8.
go back to reference Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, Cravidi C, Vanelli M, Balestrazzi P, Bernasconi S. Blood pressure behaviour and control in turner syndrome. Clin Exp Hypertens A. 1986;8:787–91.PubMed Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, Cravidi C, Vanelli M, Balestrazzi P, Bernasconi S. Blood pressure behaviour and control in turner syndrome. Clin Exp Hypertens A. 1986;8:787–91.PubMed
9.
go back to reference Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. The influence of renal and cardiovascular abnormalities on blood pressure in turner syndrome. Clin Endocrinol. 2000;52:371–7.CrossRef Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. The influence of renal and cardiovascular abnormalities on blood pressure in turner syndrome. Clin Endocrinol. 2000;52:371–7.CrossRef
10.
go back to reference Los E, Quezada E, Chen Z, Lapidus J, Silberbach M. Pilot study of blood pressure in girls with turner syndrome: an awareness gap, clinical associations, and new hypotheses. Hypertension. 2016;68:133–6.CrossRefPubMed Los E, Quezada E, Chen Z, Lapidus J, Silberbach M. Pilot study of blood pressure in girls with turner syndrome: an awareness gap, clinical associations, and new hypotheses. Hypertension. 2016;68:133–6.CrossRefPubMed
11.
go back to reference Knisely AS, Sweeney K, Ambler MW. Pheochromocytoma and sudden death as a result of cerebral infarction in Turner's syndrome: report of a case. J Forensic Sci. 1988;33:1497–502.CrossRefPubMed Knisely AS, Sweeney K, Ambler MW. Pheochromocytoma and sudden death as a result of cerebral infarction in Turner's syndrome: report of a case. J Forensic Sci. 1988;33:1497–502.CrossRefPubMed
12.
go back to reference Landin-Wilhelmsen K, Bryman I, Hanson C, Hanson L. Spontaneous pregnancies in a turner syndrome woman with Y-chromosome mosaicism. J Assist Reprod Genet. 2004;21:229–30.CrossRefPubMedPubMedCentral Landin-Wilhelmsen K, Bryman I, Hanson C, Hanson L. Spontaneous pregnancies in a turner syndrome woman with Y-chromosome mosaicism. J Assist Reprod Genet. 2004;21:229–30.CrossRefPubMedPubMedCentral
13.
go back to reference Chaker F, Chihaoui M, Yazidi M, Bouyahia M, Slimane H. Pheochromocytoma in a 45 X, iso (Xq) turner syndrome. Ann Endocrinol. 2016;77:57–9.CrossRef Chaker F, Chihaoui M, Yazidi M, Bouyahia M, Slimane H. Pheochromocytoma in a 45 X, iso (Xq) turner syndrome. Ann Endocrinol. 2016;77:57–9.CrossRef
14.
go back to reference Holl RW, Kunze D, Etzrodt H, Teller W, Heinze E. Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr. 1994;153:11–6.CrossRefPubMed Holl RW, Kunze D, Etzrodt H, Teller W, Heinze E. Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr. 1994;153:11–6.CrossRefPubMed
15.
go back to reference Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care. 1998;21:1062–70.CrossRefPubMed Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care. 1998;21:1062–70.CrossRefPubMed
16.
go back to reference Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin N Am. 2014;43:103–22.CrossRef Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin N Am. 2014;43:103–22.CrossRef
17.
go back to reference Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS. Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab. 2005;90:2948–53.CrossRefPubMed Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS. Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab. 2005;90:2948–53.CrossRefPubMed
18.
go back to reference Radetti G, Crepaz R, Milanesi O, Paganini C, Cesaro A, Rigon F, Pitscheider W. Cardiac performance in Turner’s syndrome patients on growth hormone therapy. Horm Res. 2001;55:240–4.PubMed Radetti G, Crepaz R, Milanesi O, Paganini C, Cesaro A, Rigon F, Pitscheider W. Cardiac performance in Turner’s syndrome patients on growth hormone therapy. Horm Res. 2001;55:240–4.PubMed
19.
go back to reference Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.CrossRefPubMed Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.CrossRefPubMed
20.
go back to reference Brant WO, Rajimwale A, Lovell MA, Travers SH, Furness PD 3rd, Sorensen M, Oottamasathien S, Koyle MA. Gonadoblastoma and turner syndrome. J Urol. 2006;175:1858–60.CrossRefPubMed Brant WO, Rajimwale A, Lovell MA, Travers SH, Furness PD 3rd, Sorensen M, Oottamasathien S, Koyle MA. Gonadoblastoma and turner syndrome. J Urol. 2006;175:1858–60.CrossRefPubMed
21.
go back to reference Sivakumaran TA, Ghose S, Kumar H, Singha U, Kucheria K. Nongonadal neoplasia in patients with turner syndrome. J Environ Pathol Toxicol Oncol. 1999;18:339–47.PubMed Sivakumaran TA, Ghose S, Kumar H, Singha U, Kucheria K. Nongonadal neoplasia in patients with turner syndrome. J Environ Pathol Toxicol Oncol. 1999;18:339–47.PubMed
22.
go back to reference Kamoun M, Mnif MF, Rekik N, Belguith N, Charfi N, Mnif L, Elleuch M, Mnif F, Kamoun T, Mnif Z, Kamoun H, Sellami-Boudawara T, Hachicha M, Abid M. Ganglioneuroma of adrenal gland in a patient with turner syndrome. Ann Diagn Pathol. 2010;14:133–6.CrossRefPubMed Kamoun M, Mnif MF, Rekik N, Belguith N, Charfi N, Mnif L, Elleuch M, Mnif F, Kamoun T, Mnif Z, Kamoun H, Sellami-Boudawara T, Hachicha M, Abid M. Ganglioneuroma of adrenal gland in a patient with turner syndrome. Ann Diagn Pathol. 2010;14:133–6.CrossRefPubMed
23.
go back to reference Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. UK clinical cytogenetics group. Cancer incidence in women with turner syndrome in great Britain: a national cohort study. Lancet Oncol. 2008;9:239–46.CrossRefPubMed Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. UK clinical cytogenetics group. Cancer incidence in women with turner syndrome in great Britain: a national cohort study. Lancet Oncol. 2008;9:239–46.CrossRefPubMed
24.
go back to reference Neumann HP, Bausch B, SR MW, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459–66.CrossRefPubMed Neumann HP, Bausch B, SR MW, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459–66.CrossRefPubMed
Metadata
Title
Pheochromocytoma as a rare cause of hypertension in a 46 X, i(X)(q10) turner syndrome: a case report and literature review
Authors
Ji Yeon Shin
Bo Hyun Kim
Young Keum Kim
Tae Hwa Kim
Eun Heui Kim
Min Jin Lee
Jong Ho Kim
Yun Kyung Jeon
Sang Soo Kim
In Joo Kim
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2018
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-018-0253-3

Other articles of this Issue 1/2018

BMC Endocrine Disorders 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.